Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies
Clinical trial NCT05986734 · UNKNOWN
Trial details
- NCT number
- NCT05986734
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.